Skip to main content

ICON9 An international phase III randomised study to evaluate the efficacy of maintenance cediranib and olaparib combination therapy or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy.

Project Member(s): Viney, R., De Abreu Lourenco, R., Vargas Parada, C.

Funding or Partner Organisation: Cancer Research UK
Cancer Research UK

Start year: 2018

FOR Codes: Health Economics, Health Policy Economic Outcomes